Download: Lonza’s Commercial Cell Therapies & Cell Characterisation Presentation

Question: Are we reaching an inflection point for the stem cell and regenerative medicine industry? While the therapeutic potential of stem cells may not fully impact healthcare for a number of years, the current concern is to ensure the roadmap for cell therapy commercialisation is debated by the industry at large and early mistakes by pioneers are quickly learnt and …

How Lonza see the commercial process of manufacturing stem cell therapies

Gaining regulatory and market approval for your stem cell based therapy is merely one of the many challenges facing cell therapy developers. The manufacturing process that follows should not be an afterthought but considered more as an integral component during clinical design and development. Some important questions need to be answered: When is the right time to invest in automated …